drugset / Trial / NCT01746745
A Study of LY2940680 in Healthy Participants
NaSingle-groupOpen-labelOther
Summary
This is a single dose study of radiolabelled LY2940680 taken by mouth in healthy participants to study how the body absorbs and removes LY2940680 from the blood. This study is for research purposes only and is not intended to treat any medical condition.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | taladegib | Small molecule | 100 mg | Oral |
Indications
No indication recorded.